|
|
|
|
|
市場調査レポート
製薬業界における医学生涯教育（CME）：適合環境におけるプログラムの有効性評価
Pharmaceutical CME: Measuring Program Effectiveness in the Compliance Environment
|
当商品の販売は、2011年12月09日を持ちまして終了しました。
Abstract
Pharmaceutical CME departments struggle to measure performance for a number of
reasons. The lack of hard measures for medical education, along with a fear of
appearing non-compliant stops many companies from tracking return on
investment (ROI). Many medical education departments use post-CME outcomes
measures to judge the effectiveness of their investments in CME events.
Unfortunately, attendance figures are the only hard measurement available from
outcomes measurements - and high attendance numbers do not always translate
into effective programs.
Cutting Edge Information' s study presents best practices and strategies for
measuring CME program effectiveness, as well as explores the recent changes
that pharmaceutical CME teams have undergone since the Office of Inspector
General (OIG) published its guidance document in 2003. The study is a
comprehensive look at the pharmaceutical industry' s strategies and support for
CME in the current compliance environment.
Pharmaceutical CME: Measuring Program Effectiveness in the Compliance
Environment explores the current challenges facing continuing medical
education, as well as includes trend analysis, successful strategies and best
practices. The study' s major focus areas include:
- CME Structure, Staffing and Spending - Cutting Edge Information
collected case studies and benchmark data to underscore CME investment trends
and reorganization strategies to remain compliant with industry regulations.
- CME Program Strategies and Goals - Analysts compared
industry-leading strategies and outlined goals for CME departments.
- Grants Process - Our study identifies best practices in
standardizing the CME grants request process. The study also outlines changes
in the process to meet with new compliance standards.
- Evaluating Program Management and Effectiveness - The most
effective CME departments in the pharmaceutical industry invest in various
vehicles to deliver medical education to target physician audiences. Cutting
Edge Information compiled best practices and industry trends regarding the
ideal CME media mix, including live events, eCME and enduring content.
- Performance Measurement - Our analysts took a strategic look at
hard and soft measures that pharma companies use to determine return on
investment and return on education.
- CME Compliance - The study outlines top compliance challenges and
presents solutions for pharmaceutical companies to operate effective CME
programs in an ever-changing compliance environment.
Charts and Graphics
- Figure 1.1: CME Department Organization: Centralized vs. Decentralized
- Figure 1.2: CME Departments' Reporting Relationships
- Figure 1.3: CME Staffing in FTEs by Company
- Figure 1.4: Average Percentage of Dedicated Staff Time Given to Media Mix
- Figure 1.5: CME Staffing Compared to Previous Year
- Figure 1.6: CME Staffing Projections for Coming Year
- Figure 1.7: Challenges to CME Program Management
- Figure 1.8: Yearly CME Budgets at Surveyed Companies
- Figure 1.9: Media Mix Spending: Budget Breakdown by Types of CME
- Figure 1.10: CME Budgets Compared to Previous Year
- Figure 1.11: CME Budget Projections for Coming Year
- Figure 2.1: Breakdown of how Companies Align their CME Activities
- Figure 2.2: Percent of CME Departments Receiving Input from Each Function
- Figure 2.3: Top Challenges Faced by Participating Pharmaceutical CME
Programs
- Figure 2.4: Effectiveness of Companies' CME Strategies
- Figure 2.5: Percent of Companies CME Strategy
- Figure 2.6: Percent of Companies Supporting CME by Continent
- Figure 4.1: Number of CME Events Sponsored Compared to Last Year
- Figure 4.2: Number of CME Events Supported by Surveyed Companies Annually
- Figure 4.3: CME Spending Per Event at Surveyed Companies
- Figure 4.4: Projections for Number of CME Events Sponsored in the Coming
Year
- Figure 4.5: Average Media Mix: Participation in Live vs. eCME Events
- Figure 4.6: Media Mix As a Percentage of Company Budget
- Figure 4.7: Media Mix as a Percentage of FTEs' Dedicated Time
- Figure 4.8: Top Challenges Faced by Participating Pharmaceutical CME
Programs
- Figure 5.1: CME Soft Goal Performance Measurement Process
- Figure 5.2: Percentage of Drug Companies that Track CME Return on
Investment (ROI)
- Figure 5.3: Companies' Self-Assessments of CME Events' Return on
Investment (ROI)
- Figure 6.1: Top Challenges Faced by Participating Pharmaceutical Companies
- Figure 6.2: US Sentencing Commission Guidelines
|
 |
